Literature DB >> 35720246

Evaluation of the acid-neutralizing capacity and other properties of antacids marketed in Morocco.

Mohamed Yafout1, Hicham Elhorr1, Ibrahim Sbai El Otmani1, Youssef Khayati1.   

Abstract

Aim: The aim of this study was to evaluate the acid-neutralizing capacity (ANC) and other properties of antacid drugs marketed in Morocco.
Methods: Samples of 12 antacids were collected from pharmacies and were subjected to the test described in the US Pharmacopoeia in order to measure their ANC. Other properties such as price and sodium content were also studied.
Results: All the tested brands met the minimal requirement of 5 mEq. However, Aluminum hydroxide/Magnesium hydroxide combinations showed a superior acid-neutralizing capacity over other products and oral suspensions showed better results compared to other pharmaceutical forms. Regarding the cost of antacids, Aluminum hydroxide/Magnesium hydroxide combinations and calcium carbonate/magnesium carbonate combinations showed the most favorable ANC/price ratio. Some of the antacids studied contain a high amount of sodium.
Conclusion: All the antacids marketed in Morocco meet the USP requirement regarding their ANC. However, the ANC value should be included in the antacids' labels so that both patients and physicians can choose the most appropriate product. The ANC value should be evaluated according to the dose of the active substance instead of the minimum labeled dosage in order to allow a better result interpretation.

Entities:  

Keywords:  acid-neutralization capacity; antacids; gastroesophageal reflux; peptic ulcer; united states pharmacopoeia

Year:  2022        PMID: 35720246      PMCID: PMC9177085          DOI: 10.15386/mpr-2082

Source DB:  PubMed          Journal:  Med Pharm Rep        ISSN: 2602-0807


  20 in total

1.  Healing of duodenal ulcer with an antacid regimen.

Authors:  W L Peterson; R A Sturdevant; H D Frankl; C T Richardson; J I Isenberg; J D Elashoff; J Q Sones; R A Gross; R W McCallum; J S Fordtran
Journal:  N Engl J Med       Date:  1977-08-18       Impact factor: 91.245

Review 2.  The physiology of gastric acid secretion.

Authors:  M M Wolfe; A H Soll
Journal:  N Engl J Med       Date:  1988-12-29       Impact factor: 91.245

3.  Self-medication of dyspepsia: how appropriate is it?

Authors:  S Sihvo; E Hemminki
Journal:  Scand J Gastroenterol       Date:  1997-09       Impact factor: 2.423

4.  Prevalence of upper gastrointestinal symptoms in the general population: a systematic review.

Authors:  R C Heading
Journal:  Scand J Gastroenterol Suppl       Date:  1999

Review 5.  Review article: alginate-raft formulations in the treatment of heartburn and acid reflux.

Authors:  K G Mandel; B P Daggy; D A Brodie; H I Jacoby
Journal:  Aliment Pharmacol Ther       Date:  2000-06       Impact factor: 8.171

6.  Prevalence of gastroesophageal reflux disease: a population-based cross-sectional study in southern Chile.

Authors:  Carlos Manterola; Luis Grande; Luis Bustos; Tamara Otzen
Journal:  Gastroenterol Rep (Oxf)       Date:  2020-02-19

7.  The pathophysiology of peptic ulcer disease.

Authors:  F P Brooks
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

8.  Acid neutralization capacity of Canadian antacid formulations.

Authors:  M E MacCara; F J Nugent; J B Garner
Journal:  Can Med Assoc J       Date:  1985-03-01       Impact factor: 8.262

Review 9.  Antacids in the treatment of peptic ulcer disease.

Authors:  V Garrigues-Gil
Journal:  Methods Find Exp Clin Pharmacol       Date:  1989

Review 10.  Cardiovascular risk associated with high sodium-containing drugs: A systematic review.

Authors:  Germain Perrin; Virginie Korb-Savoldelli; Alexandre Karras; Nicolas Danchin; Pierre Durieux; Brigitte Sabatier
Journal:  PLoS One       Date:  2017-07-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.